DRUG NAME: Atorvastatin
DRUG CLASS: HMG-CoA Reductase Inhibitor (Statin)

MECHANISM OF ACTION:
- Primary: Competitive inhibition of HMG-CoA reductase, rate-limiting enzyme in cholesterol biosynthesis
- Muscle Effects: Depletes coenzyme Q10 and impairs mitochondrial function in myocytes
- Hepatic Effects: Increases hepatic LDL receptors; rare idiosyncratic hepatotoxicity

COMMON ADVERSE EFFECTS:
- myalgia
- arthralgia
- headache
- dyspepsia
- nasopharyngitis
- elevated transaminases

SERIOUS ADVERSE EFFECTS:
- rhabdomyolysis
- myopathy
- hepatotoxicity
- new-onset diabetes
- hemorrhagic stroke

RISK FACTORS:
- elderly
- female gender
- low BMI
- multisystem disease
- drug interactions (fibrates, azoles, macrolides)
- hypothyroidism
- renal impairment

MONITORING:
- CK levels
- liver enzymes
- lipid panel

